Aurora Cannabis Inc. (TSE:ACB – Get Rating)'s share price hit a new 52-week low during mid-day trading on Friday after Stifel Nicolaus lowered their price target on the stock from C$2.15 to C$1.75. The company traded as low as C$1.52 and last traded at C$1.57, with a volume of 1403886 shares trading hands. The stock had previously closed at C$1.66.
A number of other equities research analysts have also recently issued reports on ACB. Cowen boosted their target price on shares of Aurora Cannabis from C$1.85 to C$2.00 in a research report on Tuesday, July 19th. ATB Capital raised shares of Aurora Cannabis from an "underperform" rating to a "sector perform" rating and upped their price objective for the stock from C$3.00 to C$4.00 in a research report on Thursday. Cowen upped their price objective on shares of Aurora Cannabis from C$1.85 to C$2.00 in a research report on Tuesday, July 19th. CIBC cut their price objective on shares of Aurora Cannabis from C$3.75 to C$2.50 and set a "neutral" rating for the company in a research report on Monday, September 19th. Finally, Piper Sandler cut their price objective on shares of Aurora Cannabis to C$4.00 and set a "neutral" rating for the company in a research report on Wednesday. Ten research analysts have rated the stock with a hold rating, According to data from MarketBeat, Aurora Cannabis has a consensus rating of "Hold" and an average target price of C$3.53.
Get Aurora Cannabis alerts:Aurora Cannabis Price Performance
The business's fifty day moving average price is C$1.97 and its 200 day moving average price is C$2.82. The company has a debt-to-equity ratio of 35.61, a current ratio of 5.85 and a quick ratio of 3.95. The stock has a market cap of C$485.37 million and a P/E ratio of -0.27.
Aurora Cannabis Company Profile
(Get Rating)Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
See Also
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 2 Semiconductor Stocks To Watch For Reversals
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.